Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO) (HP628026)

Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHP628026
Descripción
Tarlatamab (HP628026) is a research-grade recombinant antibody targeting CD3. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huéspedHuman
ClonalidadMonoclonal
Isotipo(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Sistema de expresión Mammalian cells
Aplicaciones probadas FCM
Objetivo Drosophila Delta homolog 3, Delta3, Delta-like protein 3, DLL3, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Nivel de endotoxinas < 10 EU/mg
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso Q9NYJ7 & P07766
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosBispecific, AMG-757, 2307488-83-9
Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Tarlatamab.

  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    Flow CytoMetry

    Flow-cytometry using anti-human DLL3 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human DLL3 monoclonal antibody (Catalog: HP628026) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    Flow cytometry

    Flow-cytometry using APC anti-human DLL3 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an APC anti-human DLL3 monoclonal antibody (Catalog HP628026) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    Flow cytometry

    Flow-cytometry using PE anti-human DLL3 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an PE anti-human DLL3 monoclonal antibody (Catalog HP628026) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human DLL3 & CD3 epsilon Bispecific Reference Antibody (Tarlatamab, RUO)

    Flow cytometry

    Flow-cytometry using FITC anti-human DLL3 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an FITC anti-human DLL3 monoclonal antibody (Catalog HP628026) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores